JP2025503251A5 - - Google Patents
Info
- Publication number
- JP2025503251A5 JP2025503251A5 JP2024544873A JP2024544873A JP2025503251A5 JP 2025503251 A5 JP2025503251 A5 JP 2025503251A5 JP 2024544873 A JP2024544873 A JP 2024544873A JP 2024544873 A JP2024544873 A JP 2024544873A JP 2025503251 A5 JP2025503251 A5 JP 2025503251A5
- Authority
- JP
- Japan
- Prior art keywords
- drug
- nlpd
- inhibitor
- inhibitors
- aforementioned
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2201139.9A GB202201139D0 (en) | 2022-01-28 | 2022-01-28 | Therapeutic agent |
| GB2201139.9 | 2022-01-28 | ||
| PCT/EP2023/052076 WO2023144341A1 (en) | 2022-01-28 | 2023-01-27 | Therapeutic agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503251A JP2025503251A (ja) | 2025-01-30 |
| JP2025503251A5 true JP2025503251A5 (https=) | 2026-02-04 |
Family
ID=80621245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544873A Pending JP2025503251A (ja) | 2022-01-28 | 2023-01-27 | 治療薬 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250241990A1 (https=) |
| EP (1) | EP4469153A1 (https=) |
| JP (1) | JP2025503251A (https=) |
| CN (1) | CN119156222A (https=) |
| AU (1) | AU2023213106A1 (https=) |
| GB (1) | GB202201139D0 (https=) |
| WO (1) | WO2023144341A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119936405A (zh) * | 2025-01-23 | 2025-05-06 | 上海市重大传染病和生物安全研究院 | 血浆IL-1Ra作为生物标志物在儿童脓毒症诊断和预后中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA761627B (en) | 1976-03-16 | 1978-01-25 | C Friedmann | Improvements in or relating to the treatment of arthritis |
| US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
| US8153166B2 (en) * | 2006-06-08 | 2012-04-10 | Chih-Hsiung Lin | Composition for prophylaxis or treatment of urinary system infection and method thereof |
| GB201617548D0 (en) * | 2016-10-17 | 2016-11-30 | Linnane Pharma Ab | Novel biological factor |
-
2022
- 2022-01-28 GB GBGB2201139.9A patent/GB202201139D0/en not_active Ceased
-
2023
- 2023-01-27 WO PCT/EP2023/052076 patent/WO2023144341A1/en not_active Ceased
- 2023-01-27 US US18/833,811 patent/US20250241990A1/en active Pending
- 2023-01-27 EP EP23705488.7A patent/EP4469153A1/en active Pending
- 2023-01-27 AU AU2023213106A patent/AU2023213106A1/en active Pending
- 2023-01-27 CN CN202380030569.XA patent/CN119156222A/zh active Pending
- 2023-01-27 JP JP2024544873A patent/JP2025503251A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024075713A5 (https=) | ||
| US12233068B2 (en) | Combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD) | |
| US20100260716A1 (en) | Compounds for treating demyelination conditions | |
| US20210401751A1 (en) | Compositions for treating viral infections and methods for same | |
| JP5970465B2 (ja) | ペプチドおよびウイルス・ノイラミニダーゼ阻害剤を含んでなる組成物 | |
| JP2005506345A5 (https=) | ||
| JP2021519764A (ja) | 線維性疾患を処置する方法 | |
| JP2022523530A5 (https=) | ||
| US6384083B1 (en) | Use of adamantane amines or structurally similar compounds for combating borna disease virus and for the prevention and treatment of affective diseases and other disorders associated with bdv infections in humans and animals | |
| JP2025503251A5 (https=) | ||
| JP2023549849A5 (https=) | ||
| JP2002519391A5 (https=) | ||
| JP2008526953A (ja) | 炎症性疾患のプラジカンテルでの治療 | |
| JP2006514001A (ja) | 痛み軽減薬剤 | |
| CN113271949A (zh) | 用于治疗骨关节炎的西地那非 | |
| WO2024078507A1 (zh) | 麦角甾醇在制备防治胃溃疡药物中的应用 | |
| US20220194986A1 (en) | Cyclic peptidomimetic for the treatment of neurological disorders | |
| JP7726067B2 (ja) | ペプチド及びその用途 | |
| JP2023534576A5 (https=) | ||
| Bale et al. | Genetic and pharmacological inhibition of PAPP-A reduces bleomycin-induced pulmonary fibrosis in aged mice via reduced IGF signaling | |
| JP2022526493A5 (https=) | ||
| EP1120408A9 (en) | Remedies for motor dysfunction and gapdh expression inhibitors | |
| HK40122845A (en) | New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (pf-ild) | |
| JP2003063995A (ja) | 免疫学的疾患の治療のための配合製剤 | |
| KR20250094840A (ko) | 사이클로-히스프로 유도체 및 이를 포함하는 섬유증의 예방, 개선 또는 치료용 조성물 |